Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1451 (17 June), doi:10.1136/bmj.332.7555.1451
| The first 150 words of the full text of this article appear below. |
EDITORHarnden et al highlight an interesting problem in the early management of meningococcal disease: although it seems intuitively obvious that prehospital antibiotic treatment should improve outcome, this is extremely difficult to demonstrate objectively.1
In theory, at least three possibilities exist for the effect of early treatment on outcome, two of which are discussed by Harnden et al.
Firstly, they postulate that antibiotic administration is beneficial but that confounding by severity makes this hard to detect.
Secondly, they explore (and reject as unlikely) the possibility that antibiotic administration worsens the outcome by precipitating the release of endotoxin.
We suggest a third possibility: that in most cases prehospital antibiotic administration has little or no effect on mortality because the traditional diagnostic criteria for meningococcal disease reflect a stage of pathogenesis at which the opportunity for treatment benefit has already passed.
Shock, meningism, and petechial rash are manifestations of the profound
Amanda J Kvalsvig, senior research fellow
amanda.kvalsvig@otago.ac.nz, Department of Public Health, Wellington School of Medicine and Health Sciences, University of Otago, PO Box 7343, Wellington, New Zealand
Michael Baker, senior lecturer
Department of Public Health, Wellington School of Medicine and Health Sciences, University of Otago, PO Box 7343, Wellington, New Zealand
Graham Mills, infectious diseases physician
Waikato Hospital, Private Bag 3200, Hamilton, New Zealand